76 The Impact of a VA DOAC Population Management Tool Flag for Concurrent Antiplatelets

Introduction: Combination anticoagulation (AC) and antiplatelet therapy (APT) is known to increase the risk of bleeding. Pharmacists at the Madison VA AC clinic (with the support of multiple specialty services) have advanced practice to include more antiplatelet deprescribing in patients requiring long term anticoagulation therapy. In 2023, an APT flag in the VA DOAC Population Management Tool was activated for a more systematic approach to assessing the combination of DOAC and APT. The current objective is to describe pharmacist interventions and impact on prescribing trends since the activation of the APT flag via the DOAC dashboard.